跳至主要内容
临床试验/NCT01544712
NCT01544712已完成不适用

Treatment of Stage 3 Osteonecrosis of the Femoral Head by Autologous Transplantation of Bone Marrow Cells: a Randomized, Controlled Double Blind Study

University of Liege2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2004年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
2
主要终点
reduction of total prosthesis

研究概览

简要总结

In stage 3 Osteonecrosis (ON) of the femoral head, a beneficial effect of bone marrow grafting was reported with a reduction of the functional evolution and the necessity of a total prosthesis placement in a non-controlled retrospective trial. Based on this experience, the investigators would like to start a randomized controlled double blind study on the effect of autologous implantation of autologous bone marrow cells into the necrotic lesion of stage 3 ON of the femoral head.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients who have a non traumatic ON of the femoral head
  • Stage 3 ON (subchondral fracture).
  • Age > 18 years
  • Be able and willing to participate in the study

排除标准

  • evidence of malignant disorder in the past five years
  • Patient unable to undergo a MRI.
  • Patient who is positive for an HIV, hepatitis B or C infection.

结局指标

主要结局

reduction of total prosthesis

时间窗: 24, 60 months

Need to undergo a surgical treatment total prosthesis

次要结局

  • Pain reduction(24, 60 months)
  • functional status(24, 60 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jean-Philippe Hauzeur

Principal investigator

University of Liege

研究点 (2)

Loading locations...

相似试验